Peregrine Capital Management’s Intercept Pharmaceuticals, Inc. ICPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q2 | – | Sell |
-87,500
| Closed | -$5.51M | – | 320 |
|
|
2020
Q1 | $5.51M | Buy |
87,500
+32
| +0% | +$2.02K | 0.2% | 148 |
|
|
2019
Q4 | $10.8M | Sell |
87,468
-80,434
| -48% | -$9.97M | 0.28% | 138 |
|
|
2019
Q3 | $11.1M | Buy |
167,902
+38,556
| +30% | +$2.56M | 0.3% | 132 |
|
|
2019
Q2 | $10.3M | Buy |
129,346
+17,259
| +15% | +$1.37M | 0.25% | 150 |
|
|
2019
Q1 | $12.5M | Buy |
112,087
+4,534
| +4% | +$507K | 0.31% | 140 |
|
|
2018
Q4 | $10.8M | Buy |
107,553
+7,615
| +8% | +$767K | 0.31% | 138 |
|
|
2018
Q3 | $12.6M | Sell |
99,938
-51,496
| -34% | -$6.51M | 0.3% | 137 |
|
|
2018
Q2 | $12.7M | Buy |
151,434
+36,189
| +31% | +$3.04M | 0.32% | 131 |
|
|
2018
Q1 | $7.09M | Sell |
115,245
-5,512
| -5% | -$339K | 0.17% | 206 |
|
|
2017
Q4 | $7.06M | Buy |
+120,757
| New | +$7.06M | 0.17% | 223 |
|